Purpose: To assess the relationship between the incidence of subconjunctival hemorrhage (SCH) and age during each season of the year, and to examine recent risk factors for SCH. Methods: A total of 161 patients with SCH aged 1–94 years were involved in the study. The age, gender, medical history and ocular history were determined for all subjects. Results: The peak age of onset of SCH was between 61 and 70 years. Fourteen patients (77.7%) had trauma or contact-lens-induced injury, and 4 patients (22.3%) among the younger patients aged 0–40 years had an unknown etiology. Among the older patients aged 61–94 years, the chief risk factor for SCH was hypertension (47.5%), followed by unknown etiology (39.4%) and then diabetes (13.1%). Conclusion: These results suggest that the major current risk factors for SCH are trauma and contact-lens-induced injury in younger patients, while hypertension is the main factor in older patients. The incidence of acute hemorrhagic conjunctivitis was decreased.

Keywords:
Subconjunctival hemorrhage, seasonal variation, Contact lens, Hypertension
1.
Fukuyama J, Hayasaka S, Yamada K, Setogawa T: Causes of subconjunctival hemorrhage. Ophthalmologica 1990;200:63–67.
2.
Pitts JF, Jardine AG, Murray SB, Barker NH: Spontaneous subconjunctival haemorrhage – a sign of hypertension? Br J Ophthalmol 1992;76:297–299.
3.
Wilson RJ: Subconjunctival hemorrhage: overview and management. J Am Optom Assoc 1986;57:376–380.
4.
Uchio E: Epidemiology. Nippon Ganka Gakkai Zasshi 2003;107:2–7.
5.
Chang CH, Lin KH, Sheu MM, Huang WL, Wang HZ, Chen CW: The change of etiological agents and clinical signs of epidemic viral conjunctivitis over an 18-year period in southern Taiwan. Graefes Arch Clin Exp Ophthalmol 2003;241:554–560.
6.
Mimura T, Yamagami S, Funatsu H, Usui T, Ono K, Araie M, Amano S: Management of subconjunctival haematoma by tissue plasminogen activator. Clin Exp Ophthalmol 2005;33:541–542.
7.
Kannel WB, Gordon T, Schwartz MJ: Systolic versus diastolic blood pressure and risk of coronary heart disease. Am J Cardiol 1971;27:335–345.
8.
Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, Horan MJ, Labarthe D: Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey, 1988–1991. Hypertension 1995;25:305–313.
9.
Izzo JL Jr, Levy D, Black HR: Clinical advisory statement: importance of systolic blood pressure in older Americans. Hypertension 2000;35:1021–1024.
10.
Franklin SS, Jacobs MJ, Wong ND, L’Italien GJ, Lapuerta P: Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey (NHANES) III. Hypertension 2001;37:869–874.
11.
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ, National Heart, Lung and Blood Institute Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure, National High Blood Pressure Education Program Coordinating Committee: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560–2572.
12.
Aoki K, Kawana R, Matsumoto I, Maekawa H, Sawada H, Sakurada N, Nobrega MJ, Del Rey Filho M, Belfort R Jr: An epidemic of acute hemorrhagic conjunctivitis in the city of Sao Paulo. Jpn J Ophthalmol 1987;31:532–537.
13.
Aoki K, Kawana R, Matsumoto I, Wadell G, de Jong JC: Viral conjunctivitis with special reference to adenovirus type 37 and enterovirus 70 infection. Jpn J Ophthalmol 1986;30:158–164.
© 2009 S. Karger AG, Basel
2009
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.